In various tumor types [62,63,64] as well as in CRC, increased beta-catenin levels have been linked to altered T-cell responses and a notable reduction in tumor-infiltrating lymphocytes (TILs), regardless of their microsatellite status [55]. The gene discussed is CTNNB1; the disease is neoplasm.